Logo image of BLCO.CA

BAUSCH + LOMB CORP (BLCO.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:BLCO - CA0717051076 - Common Stock

22.7 CAD
+0.16 (+0.71%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

4

Overall BLCO gets a fundamental rating of 4 out of 10. We evaluated BLCO against 18 industry peers in the Health Care Equipment & Supplies industry. While BLCO is still in line with the averages on profitability rating, there are concerns on its financial health. BLCO has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BLCO had positive earnings in the past year.
BLCO had a positive operating cash flow in the past year.
In multiple years BLCO reported negative net income over the last 5 years.
BLCO had a positive operating cash flow in 4 of the past 5 years.
BLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFBLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.21%, BLCO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of -4.74%, BLCO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 0.69%, BLCO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BLCO is in line with the industry average of 0.69%.
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROIC 0.69%
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
BLCO.CA Yearly ROA, ROE, ROICBLCO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

BLCO has a Operating Margin of 2.31%. This is amongst the best in the industry. BLCO outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of BLCO has declined.
BLCO's Gross Margin of 59.45% is fine compared to the rest of the industry. BLCO outperforms 61.11% of its industry peers.
In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
Industry RankSector Rank
OM 2.31%
PM (TTM) N/A
GM 59.45%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
BLCO.CA Yearly Profit, Operating, Gross MarginsBLCO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLCO is destroying value.
The number of shares outstanding for BLCO has been increased compared to 1 year ago.
The number of shares outstanding for BLCO has been increased compared to 5 years ago.
Compared to 1 year ago, BLCO has a worse debt to assets ratio.
BLCO.CA Yearly Shares OutstandingBLCO.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
BLCO.CA Yearly Total Debt VS Total AssetsBLCO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

BLCO has an Altman-Z score of 0.84. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
BLCO has a Altman-Z score of 0.84. This is amongst the best in the industry. BLCO outperforms 94.44% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that BLCO is somewhat dependend on debt financing.
BLCO's Debt to Equity ratio of 0.77 is fine compared to the rest of the industry. BLCO outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACC0.1
WACC7.26%
BLCO.CA Yearly LT Debt VS Equity VS FCFBLCO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

BLCO has a Current Ratio of 1.51. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
BLCO has a better Current ratio (1.51) than 77.78% of its industry peers.
A Quick Ratio of 0.98 indicates that BLCO may have some problems paying its short term obligations.
BLCO has a Quick ratio of 0.98. This is in the better half of the industry: BLCO outperforms 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.98
BLCO.CA Yearly Current Assets VS Current LiabilitesBLCO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

The earnings per share for BLCO have decreased strongly by -29.51% in the last year.
Looking at the last year, BLCO shows a small growth in Revenue. The Revenue has grown by 6.23% in the last year.
BLCO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.87% yearly.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%

3.2 Future

The Earnings Per Share is expected to grow by 24.18% on average over the next years. This is a very strong growth
Based on estimates for the next years, BLCO will show a small growth in Revenue. The Revenue will grow by 4.94% on average per year.
EPS Next Y-11.58%
EPS Next 2Y12.93%
EPS Next 3Y18.02%
EPS Next 5Y24.18%
Revenue Next Year6.52%
Revenue Next 2Y6.16%
Revenue Next 3Y5.72%
Revenue Next 5Y4.94%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BLCO.CA Yearly Revenue VS EstimatesBLCO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO.CA Yearly EPS VS EstimatesBLCO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 37.83 indicates a quite expensive valuation of BLCO.
Compared to the rest of the industry, the Price/Earnings ratio of BLCO indicates a rather cheap valuation: BLCO is cheaper than 100.00% of the companies listed in the same industry.
BLCO's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.31.
With a Price/Forward Earnings ratio of 20.44, BLCO is valued on the expensive side.
Based on the Price/Forward Earnings ratio, BLCO is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BLCO to the average of the S&P500 Index (36.59), we can say BLCO is valued slightly cheaper.
Industry RankSector Rank
PE 37.83
Fwd PE 20.44
BLCO.CA Price Earnings VS Forward Price EarningsBLCO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLCO indicates a rather cheap valuation: BLCO is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.01
BLCO.CA Per share dataBLCO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The decent profitability rating of BLCO may justify a higher PE ratio.
BLCO's earnings are expected to grow with 18.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.93%
EPS Next 3Y18.02%

0

5. Dividend

5.1 Amount

No dividends for BLCO!.
Industry RankSector Rank
Dividend Yield N/A

BAUSCH + LOMB CORP

TSX:BLCO (11/28/2025, 7:00:00 PM)

22.7

+0.16 (+0.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-13 2026-02-13/bmo
Inst Owners11.05%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.04B
Revenue(TTM)4.98B
Net Income(TTM)-305.00M
Analysts72
Price Target23.74 (4.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.31%
PT rev (3m)8.97%
EPS NQ rev (1m)-2.59%
EPS NQ rev (3m)-2.92%
EPS NY rev (1m)1.62%
EPS NY rev (3m)1.09%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 37.83
Fwd PE 20.44
P/S 1.15
P/FCF N/A
P/OCF 33.86
P/B 0.89
P/tB N/A
EV/EBITDA 19.01
EPS(TTM)0.6
EY2.64%
EPS(NY)1.11
Fwd EY4.89%
FCF(TTM)-0.78
FCFYN/A
OCF(TTM)0.67
OCFY2.95%
SpS19.74
BVpS25.5
TBVpS-6.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.55
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROCE 0.96%
ROIC 0.69%
ROICexc 0.71%
ROICexgc 2.27%
OM 2.31%
PM (TTM) N/A
GM 59.45%
FCFM N/A
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
ROICexc(3y)1.5%
ROICexc(5y)1.8%
ROICexgc(3y)4.98%
ROICexgc(5y)6.16%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Debt/EBITDA 9.06
Cap/Depr 85.28%
Cap/Sales 7.34%
Interest Coverage 250
Cash Conversion 31.12%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 0.98
Altman-Z 0.84
F-Score4
WACC7.26%
ROIC/WACC0.1
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-11.58%
EPS Next 2Y12.93%
EPS Next 3Y18.02%
EPS Next 5Y24.18%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.52%
Revenue Next 2Y6.16%
Revenue Next 3Y5.72%
Revenue Next 5Y4.94%
EBIT growth 1Y-39.47%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year45.28%
EBIT Next 3Y21.2%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%

BAUSCH + LOMB CORP / BLCO.CA FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 4 / 10 to BLCO.CA.


What is the valuation status for BLCO stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO.CA) has a profitability rating of 6 / 10.


What is the valuation of BAUSCH + LOMB CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BAUSCH + LOMB CORP (BLCO.CA) is 37.83 and the Price/Book (PB) ratio is 0.89.


Can you provide the financial health for BLCO stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO.CA) is 3 / 10.